Lixisenatide
Once-daily GLP-1 agonist for type 2 diabetes.
Category: Metabolic
Setmelanotide
MC4R agonist for rare genetic obesity.
Pramlintide
Amylin analog for glycemic control in insulin-dependent diabetes.
Insulin lispro
Rapid-acting insulin analog for diabetes.
Insulin aspart
Rapid-acting insulin analog for diabetes.
Insulin glargine
Long-acting basal insulin for diabetes.
Insulin degludec
Ultra-long-acting basal insulin for diabetes.
Tesamorelin
GHRH analog approved for HIV-associated lipodystrophy.
MOTS-c
Endogenous mitochondrial-derived peptide. Not FDA-approved; evidence is largely preclinical.